Extracorporeal Photopheresis as Treatment Option of Chronic Lung Allograft Dysfunction. Is ECP the Therapy of the Future?

被引：0

作者：

Benazzo, A. ^{[1
]}

Landl, M. ^{[1
]}

Mockenhuber, M. ^{[1
]}

Schwarz, S. ^{[1
]}

Murakoezy, G. O. ^{[1
]}

Lambers, C. O. ^{[1
]}

Moser, B. ^{[1
]}

Hoetzenecker, K. ^{[1
]}

Siguenza, J. O. Matilla ^{[1
]}

Lang, G. O. ^{[1
]}

Taghavi, S. ^{[1
]}

Klepetko, W. ^{[1
]}

Jaksch, P. ^{[1
]}

机构：

[1] Med Univ Vienna, Thorac Surg, Vienna, Austria

来源：

JOURNAL OF HEART AND LUNG TRANSPLANTATION | 2018年 / 37卷 / 04期

关键词：

D O I：

10.1016/j.healun.2018.01.263

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

260

引用

页码：S110 / S110

页数：1

共 50 条

[1] Extracorporeal Photopheresis (ECP) in the Management of Chronic Lung Allograft Dysfunction
Furuya, Y.
Witt, C.
Trulock, E. P.
Byers, D.
Kulkarni, H.
Tague, L. K.
Aguilar, P.
Kreisel, D.
Puri, V.
Gelman, A.
Hachem, R.
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2019, 38 (04): : S165 - S166
[2] Comparison of Extracorporeal Photopheresis and Thymoglobulin for the Treatment of Chronic Lung Allograft Dysfunction
Martos Gisbert, N.
Aguilar, M.
Laporta, R.
Lazaro, M.
Aguado, S.
Sandoval, R.
Ussetti Gil, M.
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2018, 37 (04): : S445 - S446
[3] Comparison of extracorporeal photopheresis and alemtuzumab for the treatment of chronic lung allograft dysfunction
Moniodis, Anna
Townsend, Keri
Rabin, Alexander
Aloum, Obadah
Stempel, Jessica
Burkett, Patrick
Camp, Phillip
Divo, Miguel
El-Chemaly, Souheil
Mallidi, Hari
Rosas, Ivan
Fuhlbrigge, Anne
Koo, Sophia
Goldberg, Hilary J.
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2018, 37 (03): : 340 - 348
[4] EXTRACORPOREAL PHOTOPHERESIS AS TREATMENT OF CHRONIC LUNG ALLOGRAFT DYSFUNCTION: A SINGLE CENTRE EXPERIENCE
Benazzo, A.
Schwarz, S.
Schweiger, T.
Hoetzenecker, K.
Lambers, C.
Murakoezy, G.
Taghavi, S.
Klepetko, W.
Jaksch, P.
TRANSPLANT INTERNATIONAL, 2017, 30 : 11 - 11
[5] Clinical Characteristics and Outcomes of Lung Transplant Recipients Receiving Extracorporeal Photopheresis (ECP) for Chronic Allograft Dysfunction (CLAD)
Rim, J. G.
Gordee, A. J.
Green, C. L.
Frankel, C. W.
Buckley, E. J. Bush
Eason, L. J.
Reynolds, J. M.
Palmer, S. M.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
[6] IMPACT OF EXTRACORPOREAL PHOTOPHERESIS ON LUNG FUNCTION AND MORTALITY IN CHRONIC LUNG ALLOGRAFT DYSFUNCTION
Wahab, Abdul
Wylam, Mark E.
Yadav, Hemang
Peters, Steve G.
Scott, John Pau
Kennedy, Cassie C.
Winters, Jeffrey
Pennington, Kelly
CHEST, 2023, 164 (04) : 6420A - 6421A
[7] A European Multi-Center Analysis of Extracorporeal Photopheresis as Therapy for Chronic Lung Allograft Dysfunction
Benazzo, Alberto
Bagnera, Cecilia
Ius, Fabio
Del Fante, Claudia
Gottlieb, Jens
Hoetzenecker, Konrad
Meloni, Federica
Jaksch, Peter
Greer, Mark
TRANSPLANT INTERNATIONAL, 2024, 36
[8] Comparison of Extracorporeal Photophoresis (ECP) or Alemtuzumab (AL) Treatment Efficacy for Chronic Lung Allograft Dysfunction (CLAD)
Townsend, K.
Moniodis, A.
Rabin, A.
Aloum, O.
Stempel, J.
Burkett, P.
Camp, P.
Divo, M.
El-Chemaly, S.
Mallidi, H.
Rosas, I.
Fuhlbrigge, A.
Goldberg, H. J.
Koo, S.
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2016, 35 (04): : S44 - S44
[9] Early extracorporeal photopheresis treatment is associated with better survival in patients with chronic or recurrent acute lung allograft dysfunction
Gautschi, Fiorenza
Vogelmann, Tobias
Ortmanns, Gernot
Knoerr, Fabian
Steinack, Carolin
Hage, Rene
Naegeli, Mirjam
Schuurmans, Mace Matthew
JOURNAL OF CLINICAL APHERESIS, 2024, 39 (03)
[10] Phenotyping Established Chronic Lung Allograft Dysfunction Predicts Extracorporeal Photopheresis Response in Lung Transplant Patients
Greer, M.
Dierich, M.
De Wall, C.
Suhling, H.
Rademacher, J.
Welte, T.
Haverich, A.
Warnecke, G.
Ivanyi, P.
Buchholz, S.
Gottlieb, J.
Fuehner, T.
AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 (04) : 911 - 918

← 1 2 3 4 5 →